Pulmonary Complications following Cytoreductive Surgery and Perioperative Chemotherapy in 147 Consecutive Patients

Table 2

Demographic and clinical features.

Patients
Male	68 (46%)
Female	79 (54%)
Age (years)
Mean ± standard deviation	49.9 (8.7%)
Median	51 (27%)
Range	23–64
Primary cancer diagnosis
Appendix	135 (92%)
Colorectal	12 (8%)
Completeness of cytoreduction
Complete	125 (85%)
Incomplete	22 (15%)
Subphrenic peritonectomy
Right	109 (74%)
Right and left	72 (49%)
Blood products
None	39 (26.5%)
1–3 units	68 (46.3%)
4 or more	40 (27.2%)
Fresh frozen plasma
None	80 (54%)
1–4 units	51 (34.7%)
5 or more	16 (10.9%)
Chemotherapy treatments
HIPEC	82 (55.8%)
HIPEC + EPIC	65 (44.2%)